Trade Summary

6 days ago, Gorman Kevin Charles, serving as Dir at Neurocrine Biosciences Inc (NBIX), sold 245,088 shares at $154.33 per share, for a total transaction value of $37,824,872.00. Following this transaction, Gorman Kevin Charles now holds 511,293 shares of NBIX.

This sale represents a 32.00% decrease in Gorman Kevin Charles's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 19, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 21, 2026 at 5:49 PM ET, 2 days after the trade was made.

Neurocrine Biosciences Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.